

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 7.41875303 |
| 2 | interferon-gamma production (GO:0032609) | 7.39258470 |
| 3 | negative thymic T cell selection (GO:0045060) | 7.27670356 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.24109453 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 7.21981968 |
| 6 | regulation of isotype switching to IgG isotypes (GO:0048302) | 7.19914838 |
| 7 | positive thymic T cell selection (GO:0045059) | 6.63634074 |
| 8 | T cell migration (GO:0072678) | 6.23883323 |
| 9 | response to interleukin-15 (GO:0070672) | 6.16877300 |
| 10 | cytidine deamination (GO:0009972) | 6.04898931 |
| 11 | cytidine metabolic process (GO:0046087) | 6.04898931 |
| 12 | cytidine catabolic process (GO:0006216) | 6.04898931 |
| 13 | positive T cell selection (GO:0043368) | 5.71358713 |
| 14 | thymic T cell selection (GO:0045061) | 5.60393502 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.54508574 |
| 16 | positive regulation of isotype switching (GO:0045830) | 5.52809769 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.52583445 |
| 18 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.46488471 |
| 19 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.45144391 |
| 20 | DNA deamination (GO:0045006) | 5.36143233 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.26384761 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.21691637 |
| 23 | negative regulation of T cell mediated immunity (GO:0002710) | 5.20975563 |
| 24 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.18124886 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 5.14851786 |
| 26 | positive regulation of DNA recombination (GO:0045911) | 5.14459792 |
| 27 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.98737008 |
| 28 | T cell selection (GO:0045058) | 4.85555204 |
| 29 | positive regulation of B cell mediated immunity (GO:0002714) | 4.81750799 |
| 30 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.81750799 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.80277336 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.80277336 |
| 33 | * regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.76132005 |
| 34 | * regulation of natural killer cell mediated immunity (GO:0002715) | 4.76132005 |
| 35 | positive regulation of humoral immune response (GO:0002922) | 4.72867515 |
| 36 | leukocyte aggregation (GO:0070486) | 4.66303530 |
| 37 | cellular defense response (GO:0006968) | 4.65891422 |
| 38 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.62964878 |
| 39 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.62161725 |
| 40 | regulation of activation of Janus kinase activity (GO:0010533) | 4.51643878 |
| 41 | activated T cell proliferation (GO:0050798) | 4.50287663 |
| 42 | lymphocyte migration (GO:0072676) | 4.49362427 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.45331253 |
| 44 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.45320739 |
| 45 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.42047599 |
| 46 | sequestering of actin monomers (GO:0042989) | 4.35255981 |
| 47 | * regulation of cell killing (GO:0031341) | 4.16689647 |
| 48 | regulation of isotype switching (GO:0045191) | 4.15954354 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 4.14557411 |
| 50 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.13648801 |
| 51 | regulation of regulatory T cell differentiation (GO:0045589) | 4.12586594 |
| 52 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.09800979 |
| 53 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.99403609 |
| 54 | mast cell activation (GO:0045576) | 3.97700067 |
| 55 | positive regulation of tolerance induction (GO:0002645) | 3.95756506 |
| 56 | * natural killer cell activation (GO:0030101) | 3.92369257 |
| 57 | * positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.89479004 |
| 58 | regulation of B cell mediated immunity (GO:0002712) | 3.88991411 |
| 59 | neutrophil activation (GO:0042119) | 3.87993388 |
| 60 | actin nucleation (GO:0045010) | 3.87654182 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 3.87320074 |
| 62 | cytolysis (GO:0019835) | 3.87000300 |
| 63 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.80993764 |
| 64 | T cell receptor signaling pathway (GO:0050852) | 3.80693525 |
| 65 | regulation of B cell differentiation (GO:0045577) | 3.78142975 |
| 66 | negative regulation of T cell apoptotic process (GO:0070233) | 3.78032575 |
| 67 | neutrophil activation involved in immune response (GO:0002283) | 3.77224291 |
| 68 | regulation of hypersensitivity (GO:0002883) | 3.74390716 |
| 69 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.73757794 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.72441454 |
| 71 | T cell differentiation involved in immune response (GO:0002292) | 3.67337966 |
| 72 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.67337966 |
| 73 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.67337966 |
| 74 | regulation of tolerance induction (GO:0002643) | 3.64961412 |
| 75 | negative regulation of viral genome replication (GO:0045071) | 3.63686058 |
| 76 | leukocyte cell-cell adhesion (GO:0007159) | 3.61008663 |
| 77 | T-helper cell differentiation (GO:0042093) | 3.58338729 |
| 78 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.58338729 |
| 79 | * positive regulation of cell killing (GO:0031343) | 3.56761731 |
| 80 | granulocyte activation (GO:0036230) | 3.56635446 |
| 81 | * positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.56412492 |
| 82 | * positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.56412492 |
| 83 | * T cell costimulation (GO:0031295) | 3.55981306 |
| 84 | positive regulation of immunoglobulin production (GO:0002639) | 3.55807882 |
| 85 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.54338618 |
| 86 | T cell proliferation (GO:0042098) | 3.52356412 |
| 87 | regulation of response to tumor cell (GO:0002834) | 3.50424410 |
| 88 | positive regulation of response to tumor cell (GO:0002836) | 3.50424410 |
| 89 | positive regulation of immune response to tumor cell (GO:0002839) | 3.50424410 |
| 90 | regulation of immune response to tumor cell (GO:0002837) | 3.50424410 |
| 91 | * lymphocyte costimulation (GO:0031294) | 3.49851305 |
| 92 | heterotypic cell-cell adhesion (GO:0034113) | 3.48663680 |
| 93 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.46052274 |
| 94 | regulation of T cell chemotaxis (GO:0010819) | 3.44850237 |
| 95 | positive regulation of T cell chemotaxis (GO:0010820) | 3.44850237 |
| 96 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.41807738 |
| 97 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.41778404 |
| 98 | positive regulation of granulocyte differentiation (GO:0030854) | 3.40427481 |
| 99 | * regulation of lymphocyte mediated immunity (GO:0002706) | 3.39186440 |
| 100 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.37280253 |
| 101 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.36892583 |
| 102 | cellular response to zinc ion (GO:0071294) | 3.36537148 |
| 103 | type I interferon signaling pathway (GO:0060337) | 3.33733482 |
| 104 | cellular response to type I interferon (GO:0071357) | 3.33733482 |
| 105 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.33213759 |
| 106 | response to type I interferon (GO:0034340) | 3.33025192 |
| 107 | lymphocyte chemotaxis (GO:0048247) | 3.32579153 |
| 108 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.31046736 |
| 109 | T cell activation involved in immune response (GO:0002286) | 3.27305685 |
| 110 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.24994110 |
| 111 | positive regulation of defense response to virus by host (GO:0002230) | 3.24260825 |
| 112 | cellular extravasation (GO:0045123) | 3.23074169 |
| 113 | alpha-beta T cell activation (GO:0046631) | 3.22864138 |
| 114 | regulation of response to interferon-gamma (GO:0060330) | 3.21603309 |
| 115 | regulation of memory T cell differentiation (GO:0043380) | 3.19602892 |
| 116 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.19236608 |
| 117 | dendritic cell chemotaxis (GO:0002407) | 3.19143246 |
| 118 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.17079708 |
| 119 | positive regulation of T cell mediated immunity (GO:0002711) | 3.17002228 |
| 120 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.16344886 |
| 121 | T cell differentiation (GO:0030217) | 3.10615648 |
| 122 | respiratory burst (GO:0045730) | 3.06589344 |
| 123 | B cell receptor signaling pathway (GO:0050853) | 3.06264819 |
| 124 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.05813567 |
| 125 | regulation of T cell mediated immunity (GO:0002709) | 3.02176615 |
| 126 | mast cell activation involved in immune response (GO:0002279) | 3.01929855 |
| 127 | mast cell degranulation (GO:0043303) | 3.01929855 |
| 128 | immunoglobulin mediated immune response (GO:0016064) | 3.01279366 |
| 129 | T cell activation (GO:0042110) | 2.96528235 |
| 130 | chemokine-mediated signaling pathway (GO:0070098) | 2.96464474 |
| 131 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.92851583 |
| 132 | response to interferon-beta (GO:0035456) | 2.91934599 |
| 133 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.89724048 |
| 134 | natural killer cell differentiation (GO:0001779) | 2.85536095 |
| 135 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.85447902 |
| 136 | regulation of calcium-mediated signaling (GO:0050848) | 2.83837875 |
| 137 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 10.5268435 |
| 138 | negative regulation of cell killing (GO:0031342) | 10.5268435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.66801272 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.32803013 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.25297933 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.95929033 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.68987650 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.65640471 |
| 7 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.51143715 |
| 8 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.28732139 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.70216791 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.40190667 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 3.29513279 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.26781252 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.08944004 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.99115874 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.86961177 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.75646917 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.68110030 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.50509549 |
| 19 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47602447 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45048607 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40945743 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.24979396 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.17638688 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.14983030 |
| 25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.08872220 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05990431 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.03740799 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02144902 |
| 29 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.99000173 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.91322764 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.84372109 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75289338 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74986017 |
| 34 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74223770 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72079790 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70857764 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.67304263 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.67289146 |
| 39 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63097513 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.60560910 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56803491 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55966708 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51613918 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50760107 |
| 45 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.49749549 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.49228258 |
| 47 | GATA3_26560356_Chip-Seq_TH2_Human | 1.48675541 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47067870 |
| 49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41015126 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.39265512 |
| 51 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38560358 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36380564 |
| 53 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.35424319 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34932160 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34462227 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30618957 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30288883 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29442618 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29233299 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26115655 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25456005 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24622967 |
| 63 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23111988 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20281027 |
| 65 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16696495 |
| 66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16442951 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15131531 |
| 68 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12766892 |
| 69 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.12700189 |
| 70 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11225044 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11018976 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10698684 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.10498519 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10398630 |
| 75 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.07101687 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05899265 |
| 77 | GATA3_26560356_Chip-Seq_TH1_Human | 1.05225145 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01878339 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00834345 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00581777 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99045320 |
| 82 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.97264446 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95705983 |
| 84 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95257934 |
| 85 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.92776673 |
| 86 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90903082 |
| 87 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90768164 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90200828 |
| 89 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89168494 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88722712 |
| 91 | AR_20517297_ChIP-Seq_VCAP_Human | 0.88375352 |
| 92 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88260902 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87391975 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87004661 |
| 95 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.86607030 |
| 96 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86224098 |
| 97 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.85948340 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85484087 |
| 99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.85195595 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84924839 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84466980 |
| 102 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84459012 |
| 103 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.83633187 |
| 104 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.82927452 |
| 105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82831843 |
| 106 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82696982 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.82657825 |
| 108 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82270073 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81582162 |
| 110 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81258239 |
| 111 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80110719 |
| 112 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.77523510 |
| 113 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.77231410 |
| 114 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.76478530 |
| 115 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.76478530 |
| 116 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.76284397 |
| 117 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.76245455 |
| 118 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.76223420 |
| 119 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.76074513 |
| 120 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.75791382 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75535744 |
| 122 | P300_27268052_Chip-Seq_Bcells_Human | 0.75472660 |
| 123 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75446484 |
| 124 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.75192576 |
| 125 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74841019 |
| 126 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.73799823 |
| 127 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.73431873 |
| 128 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72813591 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.72402077 |
| 130 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.70265617 |
| 131 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.69283667 |
| 132 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.66518230 |
| 133 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64169192 |
| 134 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63312277 |
| 135 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.61812267 |
| 136 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.60131043 |
| 137 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.59306173 |
| 138 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.59067320 |
| 139 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.58708004 |
| 140 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.57857707 |
| 141 | GATA2_19941826_ChIP-Seq_K562_Human | 0.57703990 |
| 142 | * FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.57038268 |
| 143 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.53825146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.35652652 |
| 2 | MP0006082_CNS_inflammation | 5.23816513 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.37659878 |
| 4 | MP0003763_abnormal_thymus_physiology | 4.09626364 |
| 5 | * MP0009785_altered_susceptibility_to | 3.61485586 |
| 6 | MP0000685_abnormal_immune_system | 3.42997701 |
| 7 | MP0001790_abnormal_immune_system | 3.32679822 |
| 8 | MP0005387_immune_system_phenotype | 3.32679822 |
| 9 | MP0001800_abnormal_humoral_immune | 3.22736660 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.20159110 |
| 11 | * MP0005025_abnormal_response_to | 3.11179264 |
| 12 | * MP0001819_abnormal_immune_cell | 2.95635033 |
| 13 | * MP0002420_abnormal_adaptive_immunity | 2.95513330 |
| 14 | * MP0002723_abnormal_immune_serum | 2.89976393 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.79229520 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.72620141 |
| 17 | MP0002405_respiratory_system_inflammati | 2.58111234 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.57311406 |
| 19 | MP0002006_tumorigenesis | 2.46503076 |
| 20 | MP0003448_altered_tumor_morphology | 2.45799740 |
| 21 | MP0000858_altered_metastatic_potential | 2.38994926 |
| 22 | * MP0002398_abnormal_bone_marrow | 2.38918339 |
| 23 | MP0003436_decreased_susceptibility_to | 2.36729846 |
| 24 | MP0002419_abnormal_innate_immunity | 2.34802371 |
| 25 | * MP0000716_abnormal_immune_system | 2.27586590 |
| 26 | MP0003724_increased_susceptibility_to | 2.14300716 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.14136291 |
| 28 | MP0002132_abnormal_respiratory_system | 2.12203276 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.96129223 |
| 30 | * MP0002722_abnormal_immune_system | 1.89549322 |
| 31 | MP0000703_abnormal_thymus_morphology | 1.88395077 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.86404493 |
| 33 | MP0004947_skin_inflammation | 1.85149027 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.82157994 |
| 35 | MP0004510_myositis | 1.81726311 |
| 36 | * MP0000689_abnormal_spleen_morphology | 1.76473070 |
| 37 | * MP0002429_abnormal_blood_cell | 1.75736528 |
| 38 | MP0001873_stomach_inflammation | 1.75598754 |
| 39 | MP0005310_abnormal_salivary_gland | 1.54576204 |
| 40 | MP0003045_fibrosis | 1.54275121 |
| 41 | MP0003866_abnormal_defecation | 1.54084917 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.49764080 |
| 43 | MP0008469_abnormal_protein_level | 1.45078001 |
| 44 | MP0002009_preneoplasia | 1.44954827 |
| 45 | MP0002933_joint_inflammation | 1.38883733 |
| 46 | MP0001853_heart_inflammation | 1.34067259 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.30109830 |
| 48 | MP0001851_eye_inflammation | 1.21872062 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.21363899 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.11420896 |
| 51 | MP0009764_decreased_sensitivity_to | 1.11161457 |
| 52 | MP0001348_abnormal_lacrimal_gland | 1.11135542 |
| 53 | MP0004381_abnormal_hair_follicle | 1.10414862 |
| 54 | MP0005645_abnormal_hypothalamus_physiol | 1.08890696 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.06952586 |
| 56 | MP0009763_increased_sensitivity_to | 1.06071278 |
| 57 | MP0005166_decreased_susceptibility_to | 1.03632436 |
| 58 | MP0002163_abnormal_gland_morphology | 1.02954028 |
| 59 | * MP0002019_abnormal_tumor_incidence | 1.02658873 |
| 60 | MP0001919_abnormal_reproductive_system | 1.01417885 |
| 61 | MP0002396_abnormal_hematopoietic_system | 1.00136013 |
| 62 | MP0010307_abnormal_tumor_latency | 0.99249704 |
| 63 | MP0001986_abnormal_taste_sensitivity | 0.92428650 |
| 64 | MP0000613_abnormal_salivary_gland | 0.91050631 |
| 65 | MP0003646_muscle_fatigue | 0.89091760 |
| 66 | MP0003878_abnormal_ear_physiology | 0.88398264 |
| 67 | MP0005377_hearing/vestibular/ear_phenot | 0.88398264 |
| 68 | MP0000920_abnormal_myelination | 0.86857936 |
| 69 | MP0003787_abnormal_imprinting | 0.86524869 |
| 70 | MP0000569_abnormal_digit_pigmentation | 0.86337647 |
| 71 | MP0003303_peritoneal_inflammation | 0.84742749 |
| 72 | MP0003195_calcinosis | 0.84166022 |
| 73 | MP0001765_abnormal_ion_homeostasis | 0.83725645 |
| 74 | MP0000343_altered_response_to | 0.80476512 |
| 75 | MP0008872_abnormal_physiological_respon | 0.80087894 |
| 76 | MP0000490_abnormal_crypts_of | 0.78046008 |
| 77 | MP0008877_abnormal_DNA_methylation | 0.75283923 |
| 78 | MP0005451_abnormal_body_composition | 0.74395049 |
| 79 | MP0003786_premature_aging | 0.73925872 |
| 80 | MP0002638_abnormal_pupillary_reflex | 0.73180463 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.73177765 |
| 82 | MP0003950_abnormal_plasma_membrane | 0.71015257 |
| 83 | MP0004130_abnormal_muscle_cell | 0.70536824 |
| 84 | MP0008995_early_reproductive_senescence | 0.69637063 |
| 85 | MP0002102_abnormal_ear_morphology | 0.66069745 |
| 86 | MP0003252_abnormal_bile_duct | 0.65736216 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.63663821 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.63563707 |
| 89 | MP0000372_irregular_coat_pigmentation | 0.63151720 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.62850984 |
| 91 | MP0001905_abnormal_dopamine_level | 0.60643853 |
| 92 | MP0003011_delayed_dark_adaptation | 0.60525751 |
| 93 | MP0005389_reproductive_system_phenotype | 0.58779172 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.58165639 |
| 95 | MP0003690_abnormal_glial_cell | 0.56535204 |
| 96 | MP0004142_abnormal_muscle_tone | 0.56367027 |
| 97 | MP0002095_abnormal_skin_pigmentation | 0.56328652 |
| 98 | MP0001663_abnormal_digestive_system | 0.55938906 |
| 99 | MP0001881_abnormal_mammary_gland | 0.54871585 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.54488497 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 0.53306247 |
| 102 | MP0001545_abnormal_hematopoietic_system | 0.53306247 |
| 103 | MP0005379_endocrine/exocrine_gland_phen | 0.53218944 |
| 104 | MP0008875_abnormal_xenobiotic_pharmacok | 0.53168642 |
| 105 | MP0004883_abnormal_blood_vessel | 0.53063759 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.52964236 |
| 107 | MP0002693_abnormal_pancreas_physiology | 0.52949715 |
| 108 | MP0005551_abnormal_eye_electrophysiolog | 0.52901748 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.51433036 |
| 110 | MP0005410_abnormal_fertilization | 0.50995283 |
| 111 | MP0004742_abnormal_vestibular_system | 0.50154778 |
| 112 | MP0005174_abnormal_tail_pigmentation | 0.48702778 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 0.48328014 |
| 114 | MP0000609_abnormal_liver_physiology | 0.47657226 |
| 115 | MP0008057_abnormal_DNA_replication | 0.45117727 |
| 116 | MP0000249_abnormal_blood_vessel | 0.45024416 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.44808482 |
| 118 | MP0003566_abnormal_cell_adhesion | 0.43719945 |
| 119 | MP0005076_abnormal_cell_differentiation | 0.42355183 |
| 120 | MP0003091_abnormal_cell_migration | 0.42232621 |
| 121 | MP0001191_abnormal_skin_condition | 0.41840953 |
| 122 | MP0002928_abnormal_bile_duct | 0.41477988 |
| 123 | MP0002168_other_aberrant_phenotype | 0.40523595 |
| 124 | MP0005390_skeleton_phenotype | 0.40408367 |
| 125 | MP0001243_abnormal_dermal_layer | 0.38829173 |
| 126 | MP0002877_abnormal_melanocyte_morpholog | 0.38745365 |
| 127 | MP0003183_abnormal_peptide_metabolism | 0.38639481 |
| 128 | MP0003795_abnormal_bone_structure | 0.38497110 |
| 129 | MP0000371_diluted_coat_color | 0.37542618 |
| 130 | MP0000627_abnormal_mammary_gland | 0.36450893 |
| 131 | MP0002254_reproductive_system_inflammat | 0.35478419 |
| 132 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.35281643 |
| 133 | MP0009643_abnormal_urine_homeostasis | 0.34828543 |
| 134 | MP0008873_increased_physiological_sensi | 0.34450809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of T cell number (HP:0011839) | 7.52588287 |
| 2 | T lymphocytopenia (HP:0005403) | 7.51333565 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 6.15984937 |
| 4 | Optic neuritis (HP:0100653) | 6.15984937 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 5.81647677 |
| 6 | Orchitis (HP:0100796) | 5.50466790 |
| 7 | Myositis (HP:0100614) | 5.50423870 |
| 8 | Nasal polyposis (HP:0100582) | 5.46315298 |
| 9 | Combined immunodeficiency (HP:0005387) | 5.31185917 |
| 10 | Abnormality of T cells (HP:0002843) | 4.89878260 |
| 11 | Encephalitis (HP:0002383) | 4.79875402 |
| 12 | Thyroiditis (HP:0100646) | 4.78565784 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.60539524 |
| 14 | Recurrent cutaneous fungal infections (HP:0011370) | 4.60539524 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 4.44871353 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.33435040 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.30601071 |
| 18 | Eczematoid dermatitis (HP:0000976) | 4.27805017 |
| 19 | Keratoconjunctivitis sicca (HP:0001097) | 4.23024443 |
| 20 | Recurrent bronchitis (HP:0002837) | 4.22578923 |
| 21 | Aplastic anemia (HP:0001915) | 4.09579788 |
| 22 | Recurrent abscess formation (HP:0002722) | 4.08062964 |
| 23 | Meningitis (HP:0001287) | 4.01314356 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.93005989 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.89719360 |
| 26 | Keratoconjunctivitis (HP:0001096) | 3.84951564 |
| 27 | Abnormality of eosinophils (HP:0001879) | 3.80863341 |
| 28 | Joint swelling (HP:0001386) | 3.71798094 |
| 29 | Increased IgM level (HP:0003496) | 3.68198543 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.67994417 |
| 31 | Vasculitis (HP:0002633) | 3.57869825 |
| 32 | Agammaglobulinemia (HP:0004432) | 3.55656173 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 3.53839817 |
| 34 | Stomatitis (HP:0010280) | 3.51248961 |
| 35 | Recurrent viral infections (HP:0004429) | 3.49928459 |
| 36 | Chronic otitis media (HP:0000389) | 3.43473034 |
| 37 | Leukocytosis (HP:0001974) | 3.42873553 |
| 38 | Hypoplasia of the thymus (HP:0000778) | 3.37418326 |
| 39 | Pulmonary infiltrates (HP:0002113) | 3.35548718 |
| 40 | Arterial thrombosis (HP:0004420) | 3.34593039 |
| 41 | Hypoproteinemia (HP:0003075) | 3.34033672 |
| 42 | IgG deficiency (HP:0004315) | 3.33077315 |
| 43 | Autoimmune hemolytic anemia (HP:0001890) | 3.32578225 |
| 44 | Recurrent skin infections (HP:0001581) | 3.24778476 |
| 45 | Hemoptysis (HP:0002105) | 3.16949926 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 3.12396432 |
| 47 | Obstructive lung disease (HP:0006536) | 3.12396432 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 3.08964336 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 3.08433830 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 3.00061151 |
| 51 | Chronic diarrhea (HP:0002028) | 2.94213157 |
| 52 | Abnormality of B cell number (HP:0010975) | 2.89799917 |
| 53 | Gangrene (HP:0100758) | 2.87427907 |
| 54 | Hemiplegia (HP:0002301) | 2.75404337 |
| 55 | IgM deficiency (HP:0002850) | 2.71810038 |
| 56 | Anorexia (HP:0002039) | 2.69891694 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.69629733 |
| 58 | Pulmonary embolism (HP:0002204) | 2.69451962 |
| 59 | Stomach cancer (HP:0012126) | 2.60188824 |
| 60 | Inflammation of the large intestine (HP:0002037) | 2.59399108 |
| 61 | Increased serum ferritin (HP:0003281) | 2.57482473 |
| 62 | Muscle fiber atrophy (HP:0100295) | 2.54316927 |
| 63 | Gingivitis (HP:0000230) | 2.53192772 |
| 64 | Hypoalbuminemia (HP:0003073) | 2.50858698 |
| 65 | Abnormal albumin level (HP:0012116) | 2.50858698 |
| 66 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.48086539 |
| 67 | Eosinophilia (HP:0001880) | 2.46903833 |
| 68 | Lymphopenia (HP:0001888) | 2.45679214 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.45325276 |
| 70 | Type 2 muscle fiber atrophy (HP:0003554) | 2.43690248 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38855567 |
| 72 | Congenital stationary night blindness (HP:0007642) | 2.37405594 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.36575880 |
| 74 | Increased IgE level (HP:0003212) | 2.30637250 |
| 75 | Pustule (HP:0200039) | 2.27874927 |
| 76 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.27707891 |
| 77 | Bronchitis (HP:0012387) | 2.27669717 |
| 78 | Lymphoma (HP:0002665) | 2.27212853 |
| 79 | Renal cortical cysts (HP:0000803) | 2.26501536 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.23353626 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.21059307 |
| 82 | Abnormality of iron homeostasis (HP:0011031) | 2.20473326 |
| 83 | Colitis (HP:0002583) | 2.20435846 |
| 84 | Keratitis (HP:0000491) | 2.16892463 |
| 85 | Abnormality of the pericardium (HP:0001697) | 2.15692233 |
| 86 | Abnormality of the prostate (HP:0008775) | 2.11531386 |
| 87 | Glomerulopathy (HP:0100820) | 2.10091860 |
| 88 | Acute hepatic failure (HP:0006554) | 2.08161144 |
| 89 | Pancytopenia (HP:0001876) | 2.07376914 |
| 90 | Granulocytopenia (HP:0001913) | 2.02694932 |
| 91 | Chest pain (HP:0100749) | 2.00801452 |
| 92 | Polyneuropathy (HP:0001271) | 1.99542652 |
| 93 | 3-Methylglutaconic aciduria (HP:0003535) | 1.98420118 |
| 94 | Abnormality of the fingertips (HP:0001211) | 1.97758345 |
| 95 | Recurrent sinusitis (HP:0011108) | 1.96304014 |
| 96 | Thrombocytosis (HP:0001894) | 1.96162052 |
| 97 | Abnormality of the common coagulation pathway (HP:0010990) | 1.95722720 |
| 98 | B lymphocytopenia (HP:0010976) | 1.94460124 |
| 99 | Gingival bleeding (HP:0000225) | 1.92529348 |
| 100 | Attenuation of retinal blood vessels (HP:0007843) | 1.90849365 |
| 101 | Periodontitis (HP:0000704) | 1.90844049 |
| 102 | Abnormality of the renal cortex (HP:0011035) | 1.89808259 |
| 103 | Epistaxis (HP:0000421) | 1.89500249 |
| 104 | Hyponatremia (HP:0002902) | 1.87298022 |
| 105 | Arthralgia (HP:0002829) | 1.87221028 |
| 106 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.86781274 |
| 107 | Urticaria (HP:0001025) | 1.85476784 |
| 108 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.85188202 |
| 109 | Hypochromic anemia (HP:0001931) | 1.84667449 |
| 110 | Frequent falls (HP:0002359) | 1.84029092 |
| 111 | Chronic sinusitis (HP:0011109) | 1.82353414 |
| 112 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81432102 |
| 113 | Pulmonary fibrosis (HP:0002206) | 1.80881793 |
| 114 | Sepsis (HP:0100806) | 1.79890052 |
| 115 | Microcytic anemia (HP:0001935) | 1.76350581 |
| 116 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.73136685 |
| 117 | Vertigo (HP:0002321) | 1.69150872 |
| 118 | Pancreatic cysts (HP:0001737) | 1.66948306 |
| 119 | Alveolar cell carcinoma (HP:0006519) | 1.66510738 |
| 120 | Recurrent otitis media (HP:0000403) | 1.65777048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.41932434 |
| 2 | MAP4K1 | 3.88349422 |
| 3 | JAK1 | 3.73311228 |
| 4 | MAP3K14 | 3.44170586 |
| 5 | ITK | 3.40052778 |
| 6 | CSK | 2.83617460 |
| 7 | JAK3 | 2.78677445 |
| 8 | IKBKE | 2.67145110 |
| 9 | TYK2 | 2.66188362 |
| 10 | TBK1 | 2.54856999 |
| 11 | ZAP70 | 2.31573664 |
| 12 | IRAK4 | 2.27343250 |
| 13 | TAOK3 | 2.25101942 |
| 14 | MST4 | 2.17080808 |
| 15 | BLK | 2.11060873 |
| 16 | GRK7 | 2.05850179 |
| 17 | NEK9 | 1.96925905 |
| 18 | KDR | 1.85913969 |
| 19 | STK10 | 1.84301786 |
| 20 | LCK | 1.70209618 |
| 21 | IKBKB | 1.70063896 |
| 22 | NLK | 1.54707653 |
| 23 | TESK2 | 1.51890682 |
| 24 | FGFR4 | 1.49594947 |
| 25 | ZAK | 1.41974589 |
| 26 | SYK | 1.37803465 |
| 27 | ADRBK2 | 1.37793937 |
| 28 | BTK | 1.34619442 |
| 29 | IRAK3 | 1.33535101 |
| 30 | FRK | 1.32057552 |
| 31 | PRKCQ | 1.31521824 |
| 32 | CLK1 | 1.31248666 |
| 33 | NUAK1 | 1.29829525 |
| 34 | TEC | 1.29246270 |
| 35 | MAP3K13 | 1.26652573 |
| 36 | GRK6 | 1.26555716 |
| 37 | MAP2K6 | 1.22715076 |
| 38 | VRK1 | 1.22554305 |
| 39 | FGFR3 | 1.22406843 |
| 40 | PIM1 | 1.22373545 |
| 41 | PASK | 1.21329074 |
| 42 | FES | 1.17949794 |
| 43 | EPHB1 | 1.16705938 |
| 44 | HCK | 1.12229210 |
| 45 | MAP4K2 | 1.10972078 |
| 46 | TYRO3 | 1.10645154 |
| 47 | CAMKK2 | 1.05536925 |
| 48 | CHUK | 1.03972251 |
| 49 | MUSK | 1.03834511 |
| 50 | KIT | 1.02766739 |
| 51 | MAP3K12 | 1.02622399 |
| 52 | BCKDK | 1.00893390 |
| 53 | SIK2 | 0.97656677 |
| 54 | LYN | 0.96746914 |
| 55 | TRPM7 | 0.96476357 |
| 56 | NME2 | 0.85921391 |
| 57 | MAP3K11 | 0.83503260 |
| 58 | PIK3CG | 0.81855621 |
| 59 | IRAK1 | 0.80657098 |
| 60 | STK24 | 0.79833535 |
| 61 | EPHA3 | 0.78518108 |
| 62 | SIK3 | 0.77380046 |
| 63 | JAK2 | 0.74801390 |
| 64 | CAMKK1 | 0.72722784 |
| 65 | PIK3CA | 0.71295349 |
| 66 | RPS6KA4 | 0.70165186 |
| 67 | TESK1 | 0.67705336 |
| 68 | GRK1 | 0.67035559 |
| 69 | TNK2 | 0.64836884 |
| 70 | STK4 | 0.61094342 |
| 71 | LIMK1 | 0.57532059 |
| 72 | MARK3 | 0.53057038 |
| 73 | FGR | 0.51795728 |
| 74 | TSSK6 | 0.50686953 |
| 75 | INSR | 0.50592386 |
| 76 | LRRK2 | 0.49989009 |
| 77 | IGF1R | 0.48085618 |
| 78 | ACVR1B | 0.46351482 |
| 79 | MAP3K10 | 0.46220016 |
| 80 | FYN | 0.46131788 |
| 81 | PIM2 | 0.45020142 |
| 82 | BMPR2 | 0.44440663 |
| 83 | MELK | 0.44408480 |
| 84 | PRKCH | 0.43791607 |
| 85 | MAPK13 | 0.42975812 |
| 86 | CDK4 | 0.42493777 |
| 87 | CDK9 | 0.40850487 |
| 88 | IRAK2 | 0.40619255 |
| 89 | RIPK4 | 0.40065668 |
| 90 | MAPKAPK3 | 0.39054431 |
| 91 | BMX | 0.38768267 |
| 92 | OXSR1 | 0.38297748 |
| 93 | ABL1 | 0.37943579 |
| 94 | PRKCD | 0.37417041 |
| 95 | HIPK2 | 0.37296180 |
| 96 | TGFBR2 | 0.35844416 |
| 97 | PRKD2 | 0.35641071 |
| 98 | ADRBK1 | 0.35214644 |
| 99 | TLK1 | 0.33348381 |
| 100 | RIPK1 | 0.33151236 |
| 101 | TTN | 0.32277289 |
| 102 | PTK2B | 0.31465440 |
| 103 | CSF1R | 0.31099250 |
| 104 | DMPK | 0.30002598 |
| 105 | GSK3A | 0.29281527 |
| 106 | PRPF4B | 0.28688945 |
| 107 | BRD4 | 0.28489840 |
| 108 | MAPKAPK2 | 0.28353756 |
| 109 | ERBB3 | 0.28034260 |
| 110 | CSNK1A1L | 0.27405577 |
| 111 | EIF2AK2 | 0.26733061 |
| 112 | DAPK3 | 0.26423729 |
| 113 | CSNK1A1 | 0.26163560 |
| 114 | MAP3K8 | 0.25786181 |
| 115 | MAPK11 | 0.25162221 |
| 116 | PDK1 | 0.24080956 |
| 117 | RPS6KA5 | 0.23962392 |
| 118 | STK11 | 0.23719106 |
| 119 | WNK4 | 0.22345708 |
| 120 | EGFR | 0.22318525 |
| 121 | PAK3 | 0.21894621 |
| 122 | BCR | 0.21515979 |
| 123 | INSRR | 0.19729688 |
| 124 | CDK19 | 0.19720174 |
| 125 | MATK | 0.19346061 |
| 126 | NEK6 | 0.19227221 |
| 127 | SRC | 0.18536129 |
| 128 | MAP3K5 | 0.17142667 |
| 129 | CDC42BPA | 0.16574707 |
| 130 | SIK1 | 0.16185062 |
| 131 | MAPK3 | 0.13525734 |
| 132 | RAF1 | 0.13128255 |
| 133 | PDGFRB | 0.13104156 |
| 134 | PKN1 | 0.12789507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 7.19967415 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.45649177 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.15448999 |
| 4 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.03241027 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.71740377 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.32143834 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.17840012 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.72744831 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 2.44568340 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.39835188 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.35023421 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.22840430 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92402512 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90309648 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.73685198 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64441178 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.63612630 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50963850 |
| 19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47487244 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46243692 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45043828 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32882132 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32304980 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.31637408 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26115727 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23510422 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22365359 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17340143 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16996857 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16138498 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.11430630 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09774687 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07453822 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 1.06221101 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05007337 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04650490 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.04217431 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 0.96025814 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94928643 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89506429 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 0.87147760 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 0.84708912 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 0.84174923 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84101076 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83777944 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83108507 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81914980 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79473054 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77705569 |
| 50 | * Malaria_Homo sapiens_hsa05144 | 0.71600069 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 0.71260678 |
| 52 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70317776 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68515218 |
| 54 | Asthma_Homo sapiens_hsa05310 | 0.67164733 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66322521 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65818085 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64854008 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63960397 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60867094 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59814755 |
| 61 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59534109 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.58593179 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56778053 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.56081482 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55907384 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54850519 |
| 67 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53081507 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50399444 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48938248 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47632344 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46534952 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46076709 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.45440666 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45153919 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.43357357 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42238547 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42006498 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40153718 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.37267732 |
| 80 | Morphine addiction_Homo sapiens_hsa05032 | 0.36853004 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.35989405 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.35814067 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35376059 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35367246 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31087768 |
| 86 | RNA polymerase_Homo sapiens_hsa03020 | 0.30840011 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29980464 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.29874197 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.29010067 |
| 90 | Proteasome_Homo sapiens_hsa03050 | 0.27888864 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.26234189 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25833669 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24436175 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23808286 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23772396 |
| 96 | Taste transduction_Homo sapiens_hsa04742 | 0.22412255 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21460832 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20980252 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.20452102 |
| 100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.18734717 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18514167 |
| 102 | Basal transcription factors_Homo sapiens_hsa03022 | 0.18400253 |
| 103 | Homologous recombination_Homo sapiens_hsa03440 | 0.17906202 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.16854143 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15756002 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.15166368 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.14964700 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.14691947 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.13800279 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.13731402 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13070305 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.12332916 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12262489 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12156284 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.11407737 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.10862043 |
| 117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.10728399 |
| 118 | Retinol metabolism_Homo sapiens_hsa00830 | 0.10412918 |
| 119 | Salivary secretion_Homo sapiens_hsa04970 | 0.10181595 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.09981024 |
| 121 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.09110930 |
| 122 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.08640490 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.05554450 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04308721 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.03279357 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.02408155 |
| 127 | Pathways in cancer_Homo sapiens_hsa05200 | 0.02353794 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.00794727 |
| 129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.00675420 |
| 130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.00176569 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | -0.0559164 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0458979 |
| 133 | Ribosome_Homo sapiens_hsa03010 | -0.0366321 |
| 134 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0314709 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | -0.0284723 |
| 136 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0188069 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | -0.0161905 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | -0.0092252 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0059660 |

